IL4I1 and diffuse large B-cell lymphoma: By integrating the metabolomics data with transcriptomic data, we uncovered an amino acid oxidase, IL4I1, which mediates TCA anaplerosis in ibrutinib-resistant DLBCL (Figure 6).